Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics.

van der Ende EL, Meeter LH, Stingl C, van Rooij JGJ, Stoop MP, Nijholt DAT, Sanchez-Valle R, Graff C, Öijerstedt L, Grossman M, McMillan C, Pijnenburg YAL, Laforce R Jr, Binetti G, Benussi L, Ghidoni R, Luider TM, Seelaar H, van Swieten JC.

Ann Clin Transl Neurol. 2019 Mar 7;6(4):698-707. doi: 10.1002/acn3.745. eCollection 2019 Apr.

2.

Identification of 4-Hydroxyproline at the Xaa Position in Collagen by Mass Spectrometry.

van Huizen NA, Burgers PC, Saintmont F, Brocorens P, Gerbaux P, Stingl C, Dekker LJM, IJzermans JNM, Luider TM.

J Proteome Res. 2019 May 3;18(5):2045-2051. doi: 10.1021/acs.jproteome.8b00930. Epub 2019 Apr 12.

PMID:
30945869
3.

Mycophenolate mofetil in the treatment of pediatric autoimmune central nervous system disease.

Stingl C, Van Mater H.

Dev Med Child Neurol. 2019 Apr;61(4):388. doi: 10.1111/dmcn.14098. Epub 2018 Nov 25. No abstract available.

PMID:
30474195
4.

Quantification of Calcyclin and Heat Shock Protein 90 in Sera from Women with and without Preeclampsia by Mass Spectrometry.

Güzel C, van den Berg CB, Duvekot JJ, Stingl C, van den Bosch TPP, van der Weiden M, Steegers EAP, Steegers-Theunissen RPM, Luider TM.

Proteomics Clin Appl. 2019 May;13(3):e1800181. doi: 10.1002/prca.201800181. Epub 2018 Nov 26.

5.

An Update on the Treatment of Pediatric Autoimmune Encephalitis.

Stingl C, Cardinale K, Van Mater H.

Curr Treatm Opt Rheumatol. 2018 Mar;4(1):14-28. doi: 10.1007/s40674-018-0089-z. Epub 2018 Feb 17.

6.

Proteomic alterations in early stage cervical cancer.

Güzel C, Govorukhina NI, Wisman GBA, Stingl C, Dekker LJM, Klip HG, Hollema H, Guryev V, Horvatovich PL, van der Zee AGJ, Bischoff R, Luider TM.

Oncotarget. 2018 Apr 6;9(26):18128-18147. doi: 10.18632/oncotarget.24773. eCollection 2018 Apr 6.

7.

Development of a Targeted Mass-Spectrometry Serum Assay To Quantify M-Protein in the Presence of Therapeutic Monoclonal Antibodies.

Zajec M, Jacobs JFM, Groenen PJTA, de Kat Angelino CM, Stingl C, Luider TM, De Rijke YB, VanDuijn MM.

J Proteome Res. 2018 Mar 2;17(3):1326-1333. doi: 10.1021/acs.jproteome.7b00890. Epub 2018 Feb 15.

PMID:
29424538
8.

Comparison of Targeted Mass Spectrometry Techniques with an Immunoassay: A Case Study for HSP90α.

Güzel C, Govorukhina NI, Stingl C, Dekker LJM, Boichenko A, van der Zee AGJ, Bischoff RPH, Luider TM.

Proteomics Clin Appl. 2018 Jan;12(1). doi: 10.1002/prca.201700107. Epub 2017 Oct 30.

PMID:
28975736
9.

Decreased Neuro-Axonal Proteins in CSF at First Attack of Suspected Multiple Sclerosis.

Stoop MP, Runia TF, Stingl C, van der Vuurst de Vries RM, Luider TM, Hintzen RQ.

Proteomics Clin Appl. 2017 Dec;11(11-12). doi: 10.1002/prca.201700005. Epub 2017 Oct 23.

PMID:
28941200
10.

Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformation.

Braakman RB, Stingl C, Tilanus-Linthorst MM, van Deurzen CH, Timmermans MA, Smid M, Foekens JA, Luider TM, Martens JW, Umar A.

Proteomics. 2017 Mar;17(5). doi: 10.1002/pmic.201600213.

11.

A uniaxial stress capacitive dilatometer for high-resolution thermal expansion and magnetostriction under multiextreme conditions.

Küchler R, Stingl C, Gegenwart P.

Rev Sci Instrum. 2016 Jul;87(7):073903. doi: 10.1063/1.4958957.

PMID:
27475567
12.

The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies.

De Marchi T, Braakman RB, Stingl C, van Duijn MM, Smid M, Foekens JA, Luider TM, Martens JW, Umar A.

Proteomics. 2016 May;16(10):1474-85. doi: 10.1002/pmic.201600004. Epub 2016 Apr 28.

PMID:
27030549
13.

Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera.

De Marchi T, Kuhn E, Dekker LJ, Stingl C, Braakman RB, Opdam M, Linn SC, Sweep FC, Span PN, Luider TM, Foekens JA, Martens JW, Carr SA, Umar A.

J Proteome Res. 2016 Apr 1;15(4):1230-42. doi: 10.1021/acs.jproteome.5b01119. Epub 2016 Mar 18.

PMID:
26958999
14.

Survivin Autoantibodies Are Not Elevated in Lung Cancer When Assayed Controlling for Specificity and Smoking Status.

Broodman I, VanDuijn MM, Stingl C, Dekker LJ, Germenis AE, de Koning HJ, van Klaveren RJ, Aerts JG, Lindemans J, Luider TM.

Cancer Immunol Res. 2016 Feb;4(2):165-72. doi: 10.1158/2326-6066.CIR-14-0176. Epub 2015 Dec 11.

15.

Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer.

De Marchi T, Timmermans AM, Smid M, Look MP, Stingl C, Opdam M, Linn SC, Sweep FC, Span PN, Kliffen M, van Deurzen CH, Luider TM, Foekens JA, Martens JW, Umar A.

Oncotarget. 2016 Jan 19;7(3):3098-110. doi: 10.18632/oncotarget.6521.

16.

Characteristic signatures of quantum criticality driven by geometrical frustration.

Tokiwa Y, Stingl C, Kim MS, Takabatake T, Gegenwart P.

Sci Adv. 2015 Apr 24;1(3):e1500001. doi: 10.1126/sciadv.1500001. eCollection 2015 Apr.

17.

Gray matter-related proteins are associated with childhood-onset multiple sclerosis.

Singh V, van Pelt ED, Stoop MP, Stingl C, Ketelslegers IA, Neuteboom RF, Catsman-Berrevoets CE, Luider TM, Hintzen RQ.

Neurol Neuroimmunol Neuroinflamm. 2015 Sep 24;2(5):e155. doi: 10.1212/NXI.0000000000000155. eCollection 2015 Oct.

18.

4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.

De Marchi T, Liu NQ, Stingl C, Timmermans MA, Smid M, Look MP, Tjoa M, Braakman RB, Opdam M, Linn SC, Sweep FC, Span PN, Kliffen M, Luider TM, Foekens JA, Martens JW, Umar A.

Mol Oncol. 2016 Jan;10(1):24-39. doi: 10.1016/j.molonc.2015.07.004. Epub 2015 Aug 7.

19.

Proteomics urine analysis of pregnant women suffering from multiple sclerosis.

Singh V, Stingl C, Stoop MP, Zeneyedpour L, Neuteboom RF, Smitt PS, Hintzen RQ, Luider TM.

J Proteome Res. 2015 May 1;14(5):2065-73. doi: 10.1021/pr501162w. Epub 2015 Mar 30.

PMID:
25793971
20.

Integrative analysis of genomics and proteomics data on clinical breast cancer tissue specimens extracted with acid guanidinium thiocyanate-phenol-chloroform.

Braakman RB, Bezstarosti K, Sieuwerts AM, de Weerd V, van Galen AM, Stingl C, Luider TM, Timmermans MA, Smid M, Martens JW, Foekens JA, Demmers JA, Umar A.

J Proteome Res. 2015 Mar 6;14(3):1627-36. doi: 10.1021/acs.jproteome.5b00046. Epub 2015 Feb 2.

PMID:
25611981
21.

Persistent Detwinning of Iron-Pnictide EuFe_{2}As_{2} Crystals by Small External Magnetic Fields.

Zapf S, Stingl C, Post KW, Maiwald J, Bach N, Pietsch I, Neubauer D, Löhle A, Clauss C, Jiang S, Jeevan HS, Basov DN, Gegenwart P, Dressel M.

Phys Rev Lett. 2014 Nov 28;113(22):227001. Epub 2014 Nov 26.

PMID:
25494081
22.

Laser capture microdissection of fluorescently labeled amyloid plaques from Alzheimer's disease brain tissue for mass spectrometric analysis.

Nijholt DA, Stingl C, Luider TM.

Methods Mol Biol. 2015;1243:165-73. doi: 10.1007/978-1-4939-1872-0_9.

PMID:
25384745
23.

Peptides from the variable region of specific antibodies are shared among lung cancer patients.

de Costa D, Broodman I, Calame W, Stingl C, Dekker LJ, Vernhout RM, de Koning HJ, Hoogsteden HC, Sillevis Smitt PA, van Klaveren RJ, Luider TM, Vanduijn MM.

PLoS One. 2014 May 1;9(5):e96029. doi: 10.1371/journal.pone.0096029. eCollection 2014.

24.

Uncovering effects of ex vivo protease activity during proteomics and peptidomics sample extraction in rat brain tissue by oxygen-18 labeling.

Stingl C, Söderquist M, Karlsson O, Borén M, Luider TM.

J Proteome Res. 2014 Jun 6;13(6):2807-17. doi: 10.1021/pr401232e. Epub 2014 May 1.

PMID:
24738752
25.

An integrated top-down and bottom-up proteomic approach to characterize the antigen-binding fragment of antibodies.

Dekker L, Wu S, Vanduijn M, Tolić N, Stingl C, Zhao R, Luider T, Paša-Tolić L.

Proteomics. 2014 May;14(10):1239-48. doi: 10.1002/pmic.201300366. Epub 2014 Apr 13.

PMID:
24634104
26.

Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.

Liu NQ, Stingl C, Look MP, Smid M, Braakman RB, De Marchi T, Sieuwerts AM, Span PN, Sweep FC, Linderholm BK, Mangia A, Paradiso A, Dirix LY, Van Laere SJ, Luider TM, Martens JW, Foekens JA, Umar A.

J Natl Cancer Inst. 2014 Feb;106(2):djt376. doi: 10.1093/jnci/djt376. Epub 2014 Jan 7.

27.

Cerebrospinal-fluid-derived immunoglobulin G of different multiple sclerosis patients shares mutated sequences in complementarity determining regions.

Singh V, Stoop MP, Stingl C, Luitwieler RL, Dekker LJ, van Duijn MM, Kreft KL, Luider TM, Hintzen RQ.

Mol Cell Proteomics. 2013 Dec;12(12):3924-34. doi: 10.1074/mcp.M113.030346. Epub 2013 Aug 22.

28.

Quantitative proteomic analysis of microdissected breast cancer tissues: comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches.

Liu NQ, Dekker LJ, Stingl C, Güzel C, De Marchi T, Martens JW, Foekens JA, Luider TM, Umar A.

J Proteome Res. 2013 Oct 4;12(10):4627-41. doi: 10.1021/pr4005794. Epub 2013 Sep 13.

PMID:
23957277
29.

Serum proteomics in amnestic mild cognitive impairment.

Ijsselstijn L, Papma JM, Dekker LJ, Calame W, Stingl C, Koudstaal PJ, Prins ND, Sillevis Smitt PA, Luider TM.

Proteomics. 2013 Aug;13(16):2526-33. doi: 10.1002/pmic.201200190. Epub 2013 Jul 19.

PMID:
23868823
30.

Comparative study of targeted and label-free mass spectrometry methods for protein quantification.

IJsselstijn L, Stoop MP, Stingl C, Sillevis Smitt PA, Luider TM, Dekker LJ.

J Proteome Res. 2013 Apr 5;12(4):2005-11. doi: 10.1021/pr301221f. Epub 2013 Mar 21.

PMID:
23464858
31.

Effects of natalizumab treatment on the cerebrospinal fluid proteome of multiple sclerosis patients.

Stoop MP, Singh V, Stingl C, Martin R, Khademi M, Olsson T, Hintzen RQ, Luider TM.

J Proteome Res. 2013 Mar 1;12(3):1101-7. doi: 10.1021/pr3012107. Epub 2013 Feb 4.

32.

SIMPATIQCO: a server-based software suite which facilitates monitoring the time course of LC-MS performance metrics on Orbitrap instruments.

Pichler P, Mazanek M, Dusberger F, Weilnböck L, Huber CG, Stingl C, Luider TM, Straube WL, Köcher T, Mechtler K.

J Proteome Res. 2012 Nov 2;11(11):5540-7. doi: 10.1021/pr300163u. Epub 2012 Oct 22.

33.

Peptide fingerprinting of folate-responsive proteins in human B lymphoblasts and orofacial clefting.

Bliek BJ, Guzel C, de Klein A, Stingl C, Luider TM, Lindemans J, Steegers EA, Steegers-Theunissen RP.

Eur J Clin Invest. 2012 Jul;42(7):738-50.

PMID:
22896855
34.

Minocycline effects on the cerebrospinal fluid proteome of experimental autoimmune encephalomyelitis rats.

Stoop MP, Rosenling T, Attali A, Meesters RJ, Stingl C, Dekker LJ, van Aken H, Suidgeest E, Hintzen RQ, Tuinstra T, van Gool A, Luider TM, Bischoff R.

J Proteome Res. 2012 Aug 3;11(8):4315-25. doi: 10.1021/pr300428e. Epub 2012 Jul 25.

PMID:
22768796
35.

Proteomics pipeline for biomarker discovery of laser capture microdissected breast cancer tissue.

Liu NQ, Braakman RB, Stingl C, Luider TM, Martens JW, Foekens JA, Umar A.

J Mammary Gland Biol Neoplasia. 2012 Jun;17(2):155-64. doi: 10.1007/s10911-012-9252-6. Epub 2012 May 30. Review.

36.

Profiling and identification of cerebrospinal fluid proteins in a rat EAE model of multiple sclerosis.

Rosenling T, Stoop MP, Attali A, van Aken H, Suidgeest E, Christin C, Stingl C, Suits F, Horvatovich P, Hintzen RQ, Tuinstra T, Bischoff R, Luider TM.

J Proteome Res. 2012 Apr 6;11(4):2048-60. doi: 10.1021/pr201244t. Epub 2012 Feb 23.

PMID:
22320401
37.

Optimized nLC-MS workflow for laser capture microdissected breast cancer tissue.

Braakman RB, Tilanus-Linthorst MM, Liu NQ, Stingl C, Dekker LJ, Luider TM, Martens JW, Foekens JA, Umar A.

J Proteomics. 2012 Jun 6;75(10):2844-54. doi: 10.1016/j.jprot.2012.01.022. Epub 2012 Jan 24.

PMID:
22296676
38.

A proteome comparison between physiological angiogenesis and angiogenesis in glioblastoma.

Mustafa DA, Dekker LJ, Stingl C, Kremer A, Stoop M, Sillevis Smitt PA, Kros JM, Luider TM.

Mol Cell Proteomics. 2012 Jun;11(6):M111.008466. doi: 10.1074/mcp.M111.008466. Epub 2012 Jan 25.

39.

Mass spectrometry analyses of κ and λ fractions result in increased number of complementarity-determining region identifications.

Broodman I, de Costa D, Stingl C, Dekker LJ, VanDuijn MM, Lindemans J, van Klaveren RJ, Luider TM.

Proteomics. 2012 Jan;12(2):183-91. doi: 10.1002/pmic.201100244. Epub 2011 Dec 20.

PMID:
22120973
40.

Serum levels of pregnancy zone protein are elevated in presymptomatic Alzheimer's disease.

Ijsselstijn L, Dekker LJ, Stingl C, van der Weiden MM, Hofman A, Kros JM, Koudstaal PJ, Sillevis Smitt PA, Ikram MA, Breteler MM, Luider TM.

J Proteome Res. 2011 Nov 4;10(11):4902-10. doi: 10.1021/pr200270z. Epub 2011 Sep 28.

PMID:
21879768
41.

Symmetry-breaking lattice distortion in Sr₃Ru₂O₇.

Stingl C, Perry RS, Maeno Y, Gegenwart P.

Phys Rev Lett. 2011 Jul 8;107(2):026404. Epub 2011 Jul 6.

PMID:
21797628
42.

Label-free peptide profiling of Orbitrap™ full mass spectra.

Titulaer MK, de Costa D, Stingl C, Dekker LJ, Sillevis Smitt PA, Luider TM.

BMC Res Notes. 2011 Jan 27;4:21. doi: 10.1186/1756-0500-4-21.

43.

Reproducibility of protein identification of selected cell types in Barrett's esophagus analyzed by combining laser-capture microdissection and mass spectrometry.

Stingl C, van Vilsteren FG, Guzel C, Ten Kate FJ, Visser M, Krishnadath KK, Bergman JJ, Luider TM.

J Proteome Res. 2011 Jan 7;10(1):288-98. doi: 10.1021/pr100709b. Epub 2010 Dec 3.

PMID:
21053923
44.

Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples.

Stoop MP, Coulier L, Rosenling T, Shi S, Smolinska AM, Buydens L, Ampt K, Stingl C, Dane A, Muilwijk B, Luitwieler RL, Sillevis Smitt PA, Hintzen RQ, Bischoff R, Wijmenga SS, Hankemeier T, van Gool AJ, Luider TM.

Mol Cell Proteomics. 2010 Sep;9(9):2063-75. doi: 10.1074/mcp.M900877-MCP200.

45.

Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis.

Stoop MP, Singh V, Dekker LJ, Titulaer MK, Stingl C, Burgers PC, Sillevis Smitt PA, Hintzen RQ, Luider TM.

PLoS One. 2010 Aug 27;5(8):e12442. doi: 10.1371/journal.pone.0012442.

46.

Sequencing and quantifying IgG fragments and antigen-binding regions by mass spectrometry.

de Costa D, Broodman I, Vanduijn MM, Stingl C, Dekker LJ, Burgers PC, Hoogsteden HC, Sillevis Smitt PA, van Klaveren RJ, Luider TM.

J Proteome Res. 2010 Jun 4;9(6):2937-45. doi: 10.1021/pr901114w.

PMID:
20387908
47.

A new acid mix enhances phosphopeptide enrichment on titanium- and zirconium dioxide for mapping of phosphorylation sites on protein complexes.

Mazanek M, Roitinger E, Hudecz O, Hutchins JR, Hegemann B, Mitulović G, Taus T, Stingl C, Peters JM, Mechtler K.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Feb 15;878(5-6):515-24. doi: 10.1016/j.jchromb.2009.12.017. Epub 2009 Dec 22.

PMID:
20075017
48.

Cardiac operations for North American children with rheumatic diseases: 1985-2005.

Stingl C, Moller JH, Binstadt BA.

Pediatr Cardiol. 2010 Jan;31(1):66-73. doi: 10.1007/s00246-009-9572-5. Epub 2009 Dec 5.

49.

High precision quantitative proteomics using iTRAQ on an LTQ Orbitrap: a new mass spectrometric method combining the benefits of all.

Köcher T, Pichler P, Schutzbier M, Stingl C, Kaul A, Teucher N, Hasenfuss G, Penninger JM, Mechtler K.

J Proteome Res. 2009 Oct;8(10):4743-52. doi: 10.1021/pr900451u.

PMID:
19663507
50.

Preventing carryover of peptides and proteins in nano LC-MS separations.

Mitulović G, Stingl C, Steinmacher I, Hudecz O, Hutchins JR, Peters JM, Mechtler K.

Anal Chem. 2009 Jul 15;81(14):5955-60. doi: 10.1021/ac900696m.

PMID:
19537771

Supplemental Content

Loading ...
Support Center